Professor Ben Solomon is a clinician-scientist whose clinical and translational research has identified new treatments, changed standards of care and improved outcomes for patients with lung cancer, the leading cause of cancer-related death. His work has resulted in regulatory approvals for first, second and third generation ALK TKIs, defining new and transformative standards of care in this population.
Professor Solomon’s ongoing leadership role in global clinical trials and as scientific chair and founding board member of the Thoracic Oncology Group of Australasia will ensure conduct and implementation of research that improves outcomes for lung cancer patients in Australia and worldwide.